Vyxeos 44 mg / 100 mg Liposome Injection
RxNorm 1942748 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Vyxeos 44 mg / 100 mg Liposome Injection (RxCUI 1942748). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Jazz Pharmaceuticals, Inc. 1

Jazz Pharmaceuticals, Inc.

NDC Product
Human Prescription Drug

Vyxeos
NDC 68727-745

Generic Name
(daunorubicin And Cytarabine) Liposome
Dosage Form
Injection, Powder, Lyophilized, For Suspension
Route
Intravenous
Marketing
NDA
Active Listing